Clinical Trial Update: A Phase 1/2 Study of Betalutin for Treatment of Relapsed Non-Hodgkin Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating Betalutin in relapsed non-Hodgkin lymphoma has completed. The study included follicular lymphoma, with results posted Januar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• Betalutin

Snippet

Sponsor: Nordic Nanovector | Conditions: Non-Hodgkin Lymphoma, Follicular Lymphoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-01-10